Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells

Biochemical Journal

Volumn 355, Issue 2, 2001, Pages 397-407

  Gonzalez Gronow, M ^a   Grenett, H E ^a   Weber, M R ^a   Gawdi, G ^a   Pizzo, S V ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcium signalling cascade; Matrix metalloproteinase 9 expression; Plasminogen glycoforms; Plasminogen receptors; Tumour cell invasion

Indexed keywords

BIODEGRADATION; BIOLOGICAL MEMBRANES; ENZYMES; POLYSACCHARIDES; TUMORS;

GLYCOFORMS;

CELLS;

DIPEPTIDYL PEPTIDASE IV; GELATINASE B; GLYCOPROTEIN; PLASMINOGEN; SIALIC ACID;

ARTICLE; CALCIUM SIGNALING; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ANTIGENS, CD26; BASE SEQUENCE; CALCIUM; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; PLASMINOGEN; PROSTATIC NEOPLASMS; PROTEIN BINDING; TUMOR CELLS, CULTURED;

EID: 0035871225     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3550397     Document Type: Article

References (72)

1. Matrix metalloproteinases
2. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression
3. The plasminogen activator system in tumor invasion and metastasis
4. The urokinase-type plasminogen activator system in cancer metastasis: A review
5. Control of type IV collagenase activity by components of the urokinaseplasmin system: A regulatory mechanism with cell-bound reactants
6. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoproteins and collagenous components of basement membranes
7. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator
8. Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and biphosphonate
9. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis
10. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete single metalloprotease capable of degrading basement membrane collagen
11. Purification and characterization of human 72 kDa gelatinase (type IV) collagenase. Use of immunolocalization to demonstrate the non-coordinate regulation of the 72 kDa and 95 kDa gelatinases by human fibroblasts
12. Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells
13. Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells
14. Type IV collagenase (Mr 72,000) expression in human prostate: Benign and malignant tissue
15. Matrix metalloproteinase-9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
16. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines
17. Plasminogen activator and metalloprotease activities of DU-145, PC-3, and 1-LN-PC3-1A human prostate tumors grown in nude mice: Correlation with tumor invasive behavior
18. Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts
19. Characterization of the plasminogen receptors of normal and rheumatoid arthritis synovial fibroblasts
20. Plasmin(ogen) carbohydrate chains mediate binding to dipeptidyl peptidase IV (CD26) in rheumatoid arthritis human synovial fibroblasts
21. Dipeptidyl peptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands
22. 3 integrin in prostate cancer metastasis
23. Calcium influx modulates expression of matrix metalloproteinase-2 (72 kDa type IV collagenase, gelatinase A)
24. Sialic acid content of plasminogen 2 glycoforms as regulators of fibrinolytic activity
25. The role of carbohydrate in the activation of plasminogen 2 glycoforms by streptokinase
26. The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator
27. The influence of the nature of the asparagine 289-linked oligosaccharide on the activation by urokinase and lysine binding properties of natural and recombinant human plasminogens
28. A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation by both ristocetin and collagen
29. Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrix
30. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers
31. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer
32. Plasminogen: Purification from human plasma by affinity chromatography
33. In vitro biosynthesis of plasminogen in a cell-free system directed by MRNA fractions isolated from monkey liver
34. Fractionation of sialylated oligosaccharides, glycopeptides, and glycoproteins on immobilized elderberry (Sambucus nigra L.) bark lectin
35. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum
36. New chromogenic substrates for X-prolyl dipeptidyl aminopeptidase
37. Human serum dipeptidyl peptidase IV (DPP IV) and its unique properties
38. Use of mass spectrometric molecular weight information to identify proteins in sequence databases
39. Rapid identification of proteins by peptide-mass fingerprinting
40. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecylsulfate and copolimerized substrates
41. Quantitative zymography: Detection of picogram quantities of gelatinases
42. Purification and identification of 91 kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
43. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
44. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
45. SV40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages
46. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene
47. A rapid in vitro assay for quantitating the invasive potential of tumor cells
48. Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis
49. Plasminogen binding to cell surfaces
50. Sialic acid-binding proteins: Characterization, biological function and application
51. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers
52. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin
53. Antibody targeting in metastatic colon cancer; a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts
54. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines
55. Endothelial cell and the pathogenesis of rheumatoid arthritis in humans and streptococcal cell wall arthritis in Lewis rats
56. Cell-associated plasminogen activation: Regulation and physiological functions
57. Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice
58. Catabolism of plasminogen glycoforms I and II in rabbits: Relationship to plasminogen synthesis by the rabbit liver in vitro
59. Carbohydrate of the human plasminogen variants. I. Structure of the asparagine-linked oligosaccharide unit
60. Carbohydrate of the human plasminogen variants II. Structure of the O-glycosidically linked oligosaccharide unit
61. Glu-plasminogen I and II: Their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen
62. Plasminogen II accumulates five times faster than plasminogen I at the site of a balloon de-endothelializing injury in vivo to the rabbit aorta: Comparison with other hemostatic proteins
63. Phosphorylation of human plasminogen activators and plasminogen
64. Phosphorylation of a surface receptor bound urokinase-type plasminogen activator in a human metastatic carcinomatous cell line
65. Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells
66. Protein kinase C-dependent in vivo phosphorylation of prourokinase leads to the formation of a receptor competitive antagonist
67. Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition
68. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes
69. CD26: A surface protease involved in T-cell activation
70. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin
71. The antiproliferative and antimetastatic compound L-651,482 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release
72. The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,482